- US12090193utility2024Glucagon-like Peptide 1 Receptor Agonists and Uses Thereof0 cites
- US12089576utility2024Nucleic Acids Comprising a Modified Rodent Activin a Receptor Type 1 (acvr1) Gene0 cites
- US12089575utility2024Genetically Modified Mouse That Expresses Humanized PD1 and PD-L1 Proteins0 cites
- USD1042107design2024Packaging0 cites
- US12082566utility2024Rodent Animals Expressing Human CR10 cites
- US12082565utility2024Non-human Animals Models of Retinoschisis0 cites
- US12084516utility2024Anti-c5 Antibody Combinations and Uses Thereof0 cites
- US12083141utility2024Treatment of Hyperglycemia with Solute Carrier Family 39 Member 5 (SLC39A5) Inhibitors0 cites
- US12077593utility2024Stabilized Formulations Containing Anti-interleukin-6 Receptor (IL-6R) Antibodies0 cites
- US12077570utility2024Anti-vegf Protein Compositions and Methods for Producing the Same0 cites
- US12077587utility2024Anti-cd8 Antibodies and Uses Thereof0 cites
- US12077782utility2024Viral Clearance by Low Ph Hold0 cites
- US12077603utility2024Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof0 cites
- US12070502utility2024Process for Reducing Subvisible Particles in a Pharmaceutical Formulation0 cites
- US12070460utility2024Methods of Treating Skin Cancer with Carboxypeptidase Vitellogenic Like (CPVL) Inhibitors0 cites
- US12071669utility2024Methods and Systems for Detection of Abnormal Karyotypes0 cites
- US12070506utility2024Steroids and Antibody-conjugates Thereof0 cites
- US12066246utility2024Target Residual Moisture Content for Lyophilized Drug Product0 cites
- US12065506utility2024Anti-tmprss2 Antibodies and Antigen-binding Fragments0 cites
- US12063915utility2024Humanized T Cell Co-receptor Mice0 cites